Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
2.350
-0.050 (-2.08%)
At close: May 30, 2025, 4:00 PM
2.530
+0.180 (7.66%)
After-hours: May 30, 2025, 7:59 PM EDT
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $45.79 million as of May 30, 2025. Its market cap has decreased by -50.97% in one year.
Market Cap
45.79M
Enterprise Value
23.56M
1-Year Change
-50.97%
Ranking
Category
Stock Price
$2.35
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has decreased from $62.51M to $45.79M, a decrease of -26.74%. That is a compound annual growth rate of -5.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 45.79M | -34.02% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | 51.96M | -16.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |